v3.26.3
Stockholders’ Equity (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Equity [Abstract]    
Schedule of Fair Value of Options Granted Black-Scholes-Merton Model

There were no options granted during the three and nine months ended September 30, 2026. The assumptions used to determine the fair value of options granted for the three and nine months ended September 30, 2025, using the Black-Scholes-Merton model are as follows:

 

Risk-free interest rate  3.80 to 4.50%
Expected volatility (weighted-average and range, if applicable)  96-106%
Expected term  5 to 6.5 years

The assumptions used to determine the fair value of options granted in the year ended December 31, 2025 using the Black-Scholes-Merton option model are as follows:

 

Schedule of Fair Value of Options Granted Black-Scholes-Merton Model

 

Dividend yield   - 
Risk-free interest rate   3.5% to 4.4%
Expected volatility   93.4% to 115.5%
Expected term in years   5 to 6.5  

 

The assumptions used to determine the fair value of options granted in the year ended December 31, 2024 using the Black-Scholes-Merton model are as follows:

 

Dividend yield   0%
Risk-free interest rate   3.6% to 4.2%
Expected volatility   100%
Expected term in years   6 to 6.5  
Schedule of Stock Option Activities and Related Information

A summary of the Company’s stock option activities and related information for the nine months ended September 30, 2026, is as follows

Stock Option  No. of Stock
Option
   Weighted-Average Exercise Price   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2026   44,885   $135.00    9.3 
Cancelled / Forfeited   (6,115)   617.96    - 
September 30, 2026   38,770   $58.80    8.6 
Vested and expected to vest, September 30, 2026   38,770   $58.80    8.6 

 

A summary of the Company’s stock option activities and related information for the nine months ended September 30, 2025, is as follows:

 

Stock Option  No. of Stock
Option
   Weighted-Average Exercise Price   Weighted-Average
Remaining
Contractual Life
(in Years)
 
January 1, 2025   8,758   $1,168.32    7.8 
Granted   42,986    28.80    9.7 
Exercised   -    -    - 
Expired   -    -    - 
Cancelled / Forfeited   (8,912)   -     - 
September 30, 2025   42,832   $140.52    9.0 
Vested and expected to vest, September 30, 2025   42,832   $140.52    9.0 

A summary of the Company’s stock option activities and related information for the year ended December 31, 2025 is as follows:

 

Stock Option 

No. of Stock

Option

  

Weighted-Average

Grant Date

Exercise Price

  

Weighted-Average

Remaining

Contractual Life

(In Years)

 
Balance, January 1, 2025   8,758   $1,182.60    0.65 
Granted   45,069    46.68    9.5 
Forfeited   (8,942)   -    - 
Cancelled / Forfeited   -   -   - 
Balance, December 31, 2025   44,885   $135.00    9.3 
Vested and expected to vest December 31, 2025   44,885   $135.00    9.3 

 

Stock Option 

No. of Stock

Option

  

Weighted-Average

Grant Date

Exercise Price

  

Weighted-

Average

Remaining

Contractual Life

(In Years)

 
January 1, 2024   9,526   $1,303.44    1.65 
Granted   -    -    - 
Forfeited   -    -    - 
Cancelled / Forfeited   (768)   (919.20)   - 
December 31, 2024   8,758   $1,182.60    0.65 
Schedule of Options Outstanding

The following options were outstanding at their respective exercise price as of September 30, 2026 and December 31, 2025.

 

Exercise Price Options Outstanding  September 30, 2026   December 31, 2025 
$15.24   2,083    2,083 
$26.64   1,982    1,982 
$28.80   26,585    30,408 
$76.80   611    611 
$93.60   478    478 
$96.00   2,725    2,725 
$116.16   2,907    2,907 
$374.40   832    832 
$750.48   567    567 
$1,600.80   -    2,292 
Total   38,770    44,885 

The following options were outstanding as of December 31, 2025, at their respective exercise price:

 

Exercise Price Options Outstanding  December 31, 2025 
$15.24   2,084 
$26.64   1,982 
$28.80   30,408 
$76.80   611 
$93.60   478 
$96.00   2,725 
$116.16   2,907 
$374.40   832 
$750.48   569 
$1,600.80   2,292 
Fractional share rounding (reverse stock split)   

(3

)
Total   44,885 
Schedule of Stock Compensation Expenses

Stock compensation expense for the three months ended September 30, 2026, and September 30, 2025, is as follows:

   2026   2025 
   For The Three Months Ended 
   2026   2025 
Compensation and employee benefits  $41,523   $486,707 
Professional services   -    100,000 
Total  $41,523   $586,707 

 

Stock compensation expense for the nine months ended September 30, 2026, and September 30, 2025, is as follows:

 

   2026   2025 
   For The Nine Months Ended 
   2026   2025 
Compensation and employee benefits  $141,954   $662,615 
Professional services   -    688,993 
Total  $141,954   $1,351,608 

Stock compensation expenses is comprised of the following:

 

    2025     2024  
    Year Ended December 31  
    2025     2024  
Compensation and employee benefits   $ 796,565     $ 1,575,952  
Professional services     688,993       -  
Total   $ 1,485,558     $ 1,575,952  
Schedule of Restricted Stock Units

The Company does not have any outstanding restricted stock units (“RSUs”) as of September 30, 2026. A summary of the Company’s RSU activity and related information for the nine months ended September 30, 2025, is presented below:

 

Restricted Stock Units  No. of RSU  

Weighted-Average

Grant Date

Fair Value
Per RSU

   Weighted-Average
Remaining
Contractual Life
(in Years)
 
Balance, January 1, 2025   715   $314.4    1.0 
Exercised   (358)   -    - 
Forfeited   (237)   -    - 
Balance, September 30, 2025   120   $314.4    0.5 

A summary of the Company’s RSU activities and related information for the year ended December 31, 2025 and December 31, 2024 is as follows:

 

Restricted Stock Units  No. of RSU   Weighted- Average Grant Date Fair Value Per RSU   Weighted- Average Remaining Contractual Life (in Years) 
January 1, 2025   716   $314.40    1.00 
Granted   -    -    - 
Vested   (479)   -    - 
Expired   -    -    - 
Cancelled / Forfeited   (237)   -    - 
December 31, 2025   -    -    - 

 

 

Restricted Stock Units  No. of RSU   Weighted- Average Grant Date Fair Value Per RSU   Weighted- Average Remaining Contractual Life (in Years) 
January 1, 2024   1,348   $314.40    2.00 
Granted   -    -    - 
Vested   (450)   314.40    - 
Expired   -    -    - 
Cancelled / Forfeited   (184)   314.40    - 
Fractional share rounding (reverse stock split)   2    -    - 
December 31, 2024   716    314.40    1.00